In 2011, the Space Foundation designated Regenetech Inc.'s Intrifuge CellXpansion technology as a Certified Space Technology, following the product's induction into the prestigious Space Technology Hall of Fame in early 2012.

The Space Foundation manages both the Space Certification program and the Space Technology Hall of Fame to recognize products originally developed for space that have been adapted to improve life on Earth.

Intrifuge CellXpansionFor decades, medical researchers have taken advantage of microgravity to develop or grow three-dimensional materials that cannot be made on Earth where gravity causes them to flatten. In the 1980s, NASA researchers developed a device called the "rotating wall bioreactor" that grows human cells in simulated weightlessness. In 2002, Regenetech, Inc., modified the bioreactor to produce its own Intrifuge System™ so it could produce expanded cell tissues for research.

Regenetech, through a special NASA agreement, affordably provides the technology to researchers pursuing rare disease treatments. Regenetech uses its Intrifuge System™ and intellectual property known as CellXpansion™ to develop therapies and conduct further for a wide variety of conditions, including cardio-vascular disease, diabetes, skin ailments and orthopedic applications. The same technology is used for the Epfora skin care line.

About Aribio Inc.Aribio is established in 2010 and has headquarters in Seoul, Korea. The company's vision is being development engines for new drugs and alternative approaches to help patients with unmet medical needs and its business areas are new drug development, stem cells for regenerative medicine, cosmetics, functional dietary ingredients and natural mineral water.